Please login to the form below

Not currently logged in
Email:
Password:

testosterone

This page shows the latest testosterone news and features for those working in and with pharma, biotech and healthcare.

FDA approves Myovant’s oral pill Orgovyx for prostate cancer

FDA approves Myovant’s oral pill Orgovyx for prostate cancer

In this study, Orgovyx achieved sustained testosterone suppression to castrate levels in 96.7% of patients from week five to week 48, in comparison to 88.8% for those receiving leuprolide ... It is designed to block the GnRH receptor, which in return

Latest news

More from news
Approximately 1 fully matching, plus 40 partially matching documents found.

Latest Intelligence

  • Reaching patients and HCPs during the pandemic Reaching patients and HCPs during the pandemic

    Clarus Therapeutics pushed through with the launch of its testosterone replacement tablet, Jatenzo, despite the disruption caused by COVID-19.

  • Case study: Tackle TD for Bayer UK Case study: Tackle TD for Bayer UK

    Client:Bayer UK. Agency:Virgo Health and Oi Ltd. Campaign:Tackle TD. Timescale:N/A. Testosterone deficiency affects around one million British men, but symptoms like fatigue are often ignored, and ... One million British men are estimated to have

  • Deal Watch April 2016 Deal Watch April 2016

    50 . Acerus (CA). Aytu (US). US license and commercialisation. Approved nasal testosterone for treatment of hypogonadism.

  • Deal Watch table for October 2014 Deal Watch table for October 2014

    130. TesoRx Pharma/Aspen. Licence [C]. For TSX 002 an unmodified oral  testosterone replacement.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....